Navigation Links
FluoroPharma Announces $1.6M Capital Raise
Date:6/23/2011

BOSTON, June 23, 2011 /PRNewswire/ -- FluoroPharma Medical (OTC.BB: FPMI) announced it has received subscriptions from select accredited investors for gross proceeds of $1.6 million in a private placement offering. The proceeds from this financing together with the previously announced financing in May 2011 aggregates $5.3 million. The Company intends to use the proceeds of the offering for working capital purposes.

"We are pleased that we can continue to fund the advancement of our portfolio of compounds," said Thijs Spoor, FluoroPharma's Chief Executive Officer. "This step will allow the company to significantly advance its clinical development."  Dr. David Elmaleh, Chairman of the Board of Directors and the inventor of the technology added, "the company has previously reached significant milestones and we expect to continue to focus our efforts on executing FluoroPharma's strategic plan."

Noble Capital Markets acted as placement agent and Sichenzia Ross Friedman and Ference acted as counsel on the transaction.

The securities offered in this financing transaction have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered only to qualified accredited investors. The Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares and the shares of common stock issuable upon exercise of the warrants. Any offering of the Company's securities under the resale registration statement referred to above will be made only by means of a prospectus.

This release does not constitute an offer to sell or the solicitation of
'/>"/>

SOURCE FluoroPharma Medical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FluoroPharma Announces Completion of Merger and Fund Raising
2. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
3. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
4. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
5. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
6. Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
7. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
8. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
9. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
10. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
11. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... DURHAM, N.C. , Sept. 30, 2014 /PRNewswire/ ... that Viztek LLC (Viztek), a leading provider of ... licensed HeartIT,s zero footprint patent portfolio. The licensed ... to provide access to diagnostic-quality medical images in ... part of the agreement, Viztek and its Subsidiaries ...
(Date:9/30/2014)... 2014  Come fall, many children, teenagers, and even ... want to be for Halloween. And, a number of ... contact lenses bought without a prescription. Halloween, ... purchase and wear contact lenses without a prescription. According ... consumer survey, 17 percent of Americans have worn ...
(Date:9/30/2014)... It is evident from the industry players that as a ... due to the lack of promotional activities to make consumers ... fatty acids. Among omega-3 ingredient sources algal oil is expected ... large vegetarian population in India . ... is in growth stage of its lifecycle. Omega-3 fatty acids ...
Breaking Medicine Technology:The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3Omega-3 Polyunsaturated Fatty Acids (PUFAs) - An Indian Market Overview 2
... Target Enrollment Expected in Fourth Quarter, BERKELEY ... GNTA ) announced that the Data Safety Monitoring ... Genasense (oblimersen sodium),Injection, which is the Company,s lead ... as originally planned after initial review of,blinded safety ...
... unique Ranexa(R) mechanism of action -, CHICAGO, March ... today that ranolazine significantly (p<0.001),shortened the QT interval of ... LQT3, which is caused by a genetic mutation in ... rhythm problems, including,sudden death. Ranolazine also shortened cardiac relaxation ...
Cached Medicine Technology:DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 2Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 3
(Date:9/30/2014)... 2014 Visiting Nurse Association (VNA) Health ... to announce that Steven Landers, MD, MPH, president and ... “40 Under 40” award on Monday evening. The NJBIZ ... businessmen and women who have been making headlines in ... growth, professional excellence and to the community. , Dr. ...
(Date:9/30/2014)... Louis, Missouri (PRWEB) September 30, 2014 ... announce that the SLUCare Physician Group, comprised of more ... collaborating on a number of initiatives. With the ... its network size, strengthening its market footprint to better ... St. Louis area. , SLPA is a physician-led clinically ...
(Date:9/30/2014)... September 30, 2014 The global market ... USD 38.75 billion by 2020 at an estimated CAGR ... new study by Grand View Research, Inc. Increasing prevalence ... lifestyle habits such as excessive alcohol consumption and growing ... rates is expected to serve this market as a ...
(Date:9/30/2014)... 2014 Lea Blackwell, M.D., a Breast ... patients a new, more practical and comfortable option for ... mastectomies, biopsies and lumpectomy surgeries use special bras after ... seeing her patients describe the bra as scratchy, uncomfortable ... new bra in her spare time. , Ilona ...
(Date:9/30/2014)... Red Bank, NJ (PRWEB) September 30, 2014 ... largest not-for-profit visiting nurse association—is pleased to announce that ... was honored with a NJBIZ “40 Under 40” ... of New Jersey’s most accomplished young businessmen and women ... who share a commitment to business growth, professional excellence ...
Breaking Medicine News(10 mins):Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:St. Louis Physician Alliance Expands Network and Market Footprint with Recent Addition of SLUCare Physician Group 2Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 2Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 3Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 4Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 5Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 6Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3
... ... , ... , ... ...
... The adverse affects of being overweight are not limited to ... research in the latest issue of the Journals ... (Volume 65A, Number 1). The publication presents a collection ... older persons. "One of the unanticipated consequences of ...
... exposure time , TUESDAY, Feb. 23 (HealthDay News) -- ... as much as 91 percent less radiation than standard ... generated great enthusiasm in recent years, due to its ... coronary artery disease. However, that enthusiasm has been tempered ...
... to develop dementia than non-hospitalized, study finds , TUESDAY, ... hospitalized have an increased risk of cognitive decline. , That,s ... through 2007 on 2,929 people, aged 65 and older, who ... During an average follow-up of 6.1 years, 1,287 were hospitalized ...
... ... ... ... ...
... stress hormone levels in adolescent boys and girls but ... researchers. Early treatment of depression could help reduce stress ... "This is the first time cortisol reactivity has ... obesity in girls," said Elizabeth J. Susman, the Jean ...
Cached Medicine News:Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 2Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 3Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 4Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 5Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 6Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 7Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 8Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 9Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 10Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 11Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 12Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 13Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 14Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 15Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 16Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 17Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 18Health News:Overweight middle-aged adults at greater risk for cognitive decline in later life 2Health News:New Heart CT Scans Deliver Far Less Radiation: Study 2Health News:Hospital Stays May Spur Brain Decline in Seniors 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 4Health News:Stress hormone, depression trigger obesity in girls 2
... The PowerPro® Battery System is a ... line of powered surgical instruments. The PowerPro ... software controlled battery powered instrument available on ... power system specifically designed to meet the ...
... OEC, the market leader in digital ... imaging experience and advanced technologies into ... latest entry, the MiniView 6800. This ... has the workstation components of our ...
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca...
Medicine Products: